WELLS FARGO & COMPANY/MN - TALARIS THERAPEUTICS INC ownership

TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 50 filers reported holding TALARIS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of TALARIS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$391
-17.0%
139
-10.3%
0.00%
Q2 2023$471
-93.9%
155
-96.2%
0.00%
Q1 2023$7,6874,089
+8986.7%
0.00%
Q3 2022$0
-100.0%
45
-77.0%
0.00%
Q2 2022$1,000
-85.7%
196
-73.4%
0.00%
Q1 2022$7,000
-94.7%
738
-91.5%
0.00%
Q4 2021$132,0008,6420.00%
Other shareholders
TALARIS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Qiming U.S. Ventures Management, LLC 2,932,606$7,713,00011.20%
Aisling Capital Management LP 175,000$460,0000.30%
Artal Group S.A. 2,064,262$5,429,0000.23%
Cormorant Asset Management, LP 900,649$2,369,0000.17%
Eventide Asset Management 1,561,092$4,106,0000.08%
Blackstone Inc. 8,089,315$21,2750.08%
Logos Global Management LP 197,913$521,0000.06%
Values First Advisors, Inc. 30,715$81,0000.06%
VIKING GLOBAL INVESTORS LP 3,289,617$8,652,0000.04%
CAAS CAPITAL MANAGEMENT LP 297,707$783,0000.04%
View complete list of TALARIS THERAPEUTICS INC shareholders